Skip to main content
. 2019 Aug 7;121(6):490–496. doi: 10.1038/s41416-019-0541-3

Fig. 5.

Fig. 5

Overall survival curve after surgery following concurrent chemo-radiotherapy according to programmed death ligand-1 (PD-L1) expression on tumour cells or density of stromal CD8-positive tumour-infiltrating lymphocytes. PD-L1 programmed death ligand-1, TPS tumour proportion score, cCRT concurrent chemo-radiotherapy, CD8 + TIL CD8-positive tumour-infiltrating lymphocyte